Despite partial activation of EGFR in keratinocytes, aprepitant also demonstrated dose-dependent cytotoxicity to epithelial cells in our study that was consistent with previous reports of its anti-tumor effects [20,21,22]. The gene discussed is EGFR; the disease is neoplasm.